SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-20-034018
Filing Date
2020-03-16
Accepted
2020-03-16 15:01:28
Documents
101
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tm205326d1_10k.htm 10-K 962990
2 EXHIBIT 4.1 tm205326d1_ex4-1.htm EX-4.1 18507
3 EXHIBIT 10.22 tm205326d1_ex10-22.htm EX-10.22 77194
4 EXHIBIT 21 tm205326d1_ex21.htm EX-21 2983
5 EXHIBIT 23.1 tm205326d1_ex23-1.htm EX-23.1 3159
6 EXHIBIT 31.1 tm205326d1_ex31-1.htm EX-31.1 7818
7 EXHIBIT 31.2 tm205326d1_ex31-2.htm EX-31.2 7818
8 EXHIBIT 32.1 tm205326d1_ex32-1.htm EX-32.1 5005
9 EXHIBIT 32.2 tm205326d1_ex32-2.htm EX-32.2 4851
10 GRAPHIC tm205326d1_10k-img01.jpg GRAPHIC 7717
  Complete submission text file 0001104659-20-034018.txt   7294277

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT casi-20191231.xml EX-101.INS 1759398
12 XBRL TAXONOMY EXTENSION SCHEMA casi-20191231.xsd EX-101.SCH 70884
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE casi-20191231_cal.xml EX-101.CAL 56947
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE casi-20191231_def.xml EX-101.DEF 217151
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE casi-20191231_lab.xml EX-101.LAB 505007
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE casi-20191231_pre.xml EX-101.PRE 455304
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-20713 | Film No.: 20716749
SIC: 2836 Biological Products, (No Diagnostic Substances)